Oura Slides $15.6B IPO Ring Onto Jamie Dimon’s Finger (Insiders Plan 36.5M-Share Prison Break)
Congratulations to all the Brittney’s out there who said they’d never spend $500 on a ring unless it came with a fiancee…
The numbers are in for Oura’s IPO… and I have to say… it’s quite a steep figure for a ring that may or may not be one scam anyways…
Allegedly, allegedly, allegedly. Please don’t track my sleep and sue me.
The most popular thing to come out of Finland since Angry Birds weaponized childhood obesity is seeking a valuation of up to $15.6 billion as it prepares to slide onto the Nasdaq under the ticker OURA.
Oura and its existing investors plan to sell 50 million shares for between $40 and $44 apiece, raising as much as $2.2 billion.
Translation: for the same price as a meal for 2 at Cracker Barrel, investors can finally lose sleep without purchasing the actual ring.
The company itself will sell 13.5 million shares, while current shareholders plan to dump (I’m sorry, offer) another 36.5 million.
That means nearly three-quarters of the IPO is insiders and early backers graciously giving the public an opportunity to hold their bags.
Call it an IPO if you want. I’m watching insiders conduct a 36.5-million-share prison break.
To give them their flowers, Oura has built one hell of a business around telling people that drinking bourbon until midnight may negatively affect their recovery.
The company sold approximately 3.6 million rings over the past year and generated $1.21 billion in revenue during the nine months ended June 30, up 74% from the same period last year.
Oura also had more than five million paid members subscribing to its app for $5.99 per month or $69.99 annually.
Yes, you pay up to $499 for the ring…
Then pay Oura rent to access the health information collected from your own finger.
“What kind of sorcery is this?” -Peloton’s entire board
The ring tracks more than 50 health metrics, including heart rate, activity, sleep, nutrition, fertility and medication monitoring. There’s even an AI assistant called Oura Advisor that analyzes the data and provides personalized insights.
Basically, Oura created a tiny metal parole officer that monitors your body around the clock and sends push notifications every time you make a poor decision.
“Your resting heart rate was elevated last night.”
Yeah, no sh*t. I piled my entire net worth into Bitcoin at all time highs. -hopefully not you
Speaking of money, the financials require their own wellness check.
Oura produced $60.8 million in net income during the nine-month period, but reported a massive $924.3 million net loss attributable to common stockholders after accounting for a deemed dividend tied to certain preferred shares.
So while the underlying business made money, the accounting department dragged common shareholders nearly $1 billion into the red.
Oura was valued at approximately $11 billion during its 2025 funding round. Now it wants you to pay $15.6 billion for a company selling titanium sleep trackers to people who already own Apple Watches.
Goldman Sachs, Morgan Stanley and JPMorgan are leading the offering holding the door open for exiting shareholders, while Fidelity and several venture-capital firms remain among Oura’s largest investors.
Now public investors must decide whether Oura is the future of personalized healthcare…
Or WebMD for your finger with a $15.6 billion valuation and a monthly cover charge.
Get some rest, folks. The bag transfer begins at the opening bell.
At the time of publishing this article, Stocks.News holds positions in Apple as mentioned in the article.